A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 17, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Nov 5, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the IMAX SEC filings page.
Imax Corp (IMAX) reported $484.0M in revenue over the twelve months to Sep 30, 2026, up 28.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
IMAX's 2025 rebound converted modest revenue growth into outsized operating profit and cash generation without a matching capital-spending surge.
From FY2023 to FY2025, revenue increased9.4% while operating income rose67.1% , indicating that margin structure and cost absorption, not volume alone, drove the improvement. Cash conversion strengthened alongside profitability: free-cash-flow margin expanded15.1 percentage points over that span while FY2025 capital expenditures were just2.0% of revenue.
FY2025 revenue reached
Operating cash flow was
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 4 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Imax Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. Imax Corp scores 67/100 on it among other operating companies.
Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. Imax Corp scores 47/100 on it among other operating companies.
Imax Corp carried $1.38 of total liabilities for every $1 of shareholders' equity at the end of fiscal year 2025. With no long-term debt figure for fiscal year 2025, Imax Corp is ranked on that ratio rather than on net debt against EBITDA, a lower ratio being the safer one, and scores 25/100 among other operating companies measured the same way.
Not available for Imax Corp, so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.
Cash Flow ranks operating companies on their free cash flow margin, which is operating cash flow less capital spending as a share of revenue, averaged over the last three fiscal years with the newest weighted most. Imax Corp scores 89/100 on it among other operating companies.
Not available for Imax Corp, so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.
Imax Corp passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.
For every $1 of reported earnings, Imax Corp generates $3.64 in operating cash flow ($127.1M OCF vs $34.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Imax Corp earns $11.44 in operating income for every $1 of interest expense ($84.2M vs $7.4M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Imax Corp generated $174.6M in revenue in Q3 2026. This represents an increase of 63.7% from the same quarter a year earlier. Against the prior quarter it is up 69.7%.
Imax Corp's EBITDA was $101.7M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 127.8% from the same quarter a year earlier. Against the prior quarter it is up 179.0%.
Imax Corp reported $113.8M in net income in Q3 2026. This represents an increase of 450.9% from the same quarter a year earlier. Against the prior quarter it is up 638.9%.
Imax Corp earned $1.96 per diluted share (EPS) in Q3 2026. This represents an increase of 429.7% from the same quarter a year earlier. Against the prior quarter it is up 625.9%.
Cash & Balance Sheet
Imax Corp generated $84.2M in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 29.9% from the same quarter a year earlier. Against the prior quarter it is up 163.3%.
Imax Corp held $207.9M in cash as of Q3 2026; no long-term debt figure is on record for that period.
Not reported for Q3 2026.
Margins & Returns
Imax Corp's gross margin was 72.4% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 9.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 11.2 percentage points.
Imax Corp's operating margin was 42.9% in Q3 2026, reflecting core business profitability. This is up 15.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 22.7 percentage points.
Imax Corp's net profit margin was 65.2% in Q3 2026, showing the share of revenue converted to profit. This is up 45.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 50.2 percentage points.
Imax Corp's quarterly ROE was 23.2% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 17.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 18.8 percentage points.
Capital Allocation
Imax Corp invested $1.9M in research and development in Q3 2026. This represents an increase of 26.2% from the same quarter a year earlier. Against the prior quarter it is up 14.8%.
Imax Corp invested $1.9M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 29.2% from the same quarter a year earlier. Against the prior quarter it is up 9147.6%.
Not reported for Q3 2026.
IMAX Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $174.6M+63.7% | $102.8M+12.2% | $81.4M-6.1% | $125.2M+35.1% | $106.7M+16.6% | $91.7M+3.1% | $86.7M+9.5% | $92.7M+7.7% |
| Cost of Revenue | $48.3M+22.5% | $39.9M+4.9% | $35.6M+6.2% | $53.1M+19.8% | $39.4M-2.6% | $38.1M-15.4% | $33.5M+3.9% | $44.3M+4.7% |
| Gross Profit | $126.3M+87.8% | $62.9M+17.3% | $45.8M-13.9% | $72.1M+49.2% | $67.3M+31.9% | $53.6M+22.0% | $53.2M+13.4% | $48.4M+10.7% |
| R&D Expenses | $1.9M+26.2% | $1.7M+7.3% | $1.8M+36.9% | $1.5M+26.2% | $1.5M | $1.5M-24.1% | $1.3M-39.7% | $1.1M-57.8% |
| SG&A Expenses | $39.1M+14.2% | $34.5M-2.2% | $32.5M-2.9% | $35.5M+9.4% | $34.2M+8.7% | $35.3M-6.0% | $33.5M+7.1% | $32.4M-7.6% |
| Operating Income | $74.9M+157.8% | $20.8M+44.8% | $10.0M-40.5% | $24.1M+153.4% | $29.0M+49.6% | $14.3M+399.5% | $16.7M+38.7% | $9.5M+247.3% |
| EBITDA | $101.7M+127.8% | $36.4M+20.5% | $25.2M-20.4% | $40.1M+53.7% | $44.7M+30.1% | $30.2M+39.3% | $31.6M+16.2% | $26.1M+60.4% |
| Interest Expense | $1.8M-3.2% | $2.0M+1.8% | $1.9M+5.3% | $1.8M+11.4% | $1.8M-18.2% | $1.9M-15.6% | $1.8M-7.4% | $1.6M-9.0% |
| Income Tax | -$43.3M-931.9% | $3.5M+192.7% | $2.4M-66.8% | $4.1M+179.8% | $5.2M+119.1% | $1.2Mn/m | $7.3M+41.2% | $1.5Mn/m |
| Net Income | $113.8M+450.9% | $15.4M+36.8% | $4.2M+81.6% | $637K-88.0% | $20.7M+48.7% | $11.3M+214.1% | $2.3M-28.9% | $5.3M+108.9% |
| EPS (Basic) | $2.07+444.7% | $0.28+33.3% | $0.08+100.0% | $0.01-90.0% | $0.38+46.2% | $0.21+200.0% | $0.04-33.3% | $0.10+100.0% |
| EPS (Diluted) | $1.96+429.7% | $0.27+35.0% | $0.07+75.0% | $0.01-88.9% | $0.37+42.3% | $0.20+185.7% | $0.04-33.3% | $0.09+80.0% |
| Diluted Shares (Avg) | 58M+4.4% | 57M+2.6% | 56M+2.6% | N/A | 56M+2.7% | 55M+3.2% | 55M+2.9% | N/A |
IMAX Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'25Filing | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.0B+15.8% | $917.9M+5.7% | $893.2M+5.3% | $894.0M+7.7% | $889.6M+5.0% | $868.6M+5.0% | $848.3M+2.9% | $830.4M+1.9% |
| Cash & Equivalents | $207.9M+45.3% | $159.9M+46.4% | $146.0M+50.4% | $151.2M+50.3% | $143.1M+36.9% | $109.3M+19.3% | $97.1M+19.8% | $100.6M+32.0% |
| Inventory | $45.2M+9.1% | $39.2M+6.9% | $35.8M+12.9% | $32.5M-1.0% | $41.4M+10.2% | $36.7M-2.9% | $31.7M-12.2% | $32.8M+4.0% |
| Accounts Receivable | $139.0M+28.2% | $114.6M-9.8% | $108.5M-11.3% | $108.1M+0.4% | $108.4M-5.1% | $126.9M+4.5% | $122.3M-13.0% | $107.7M-21.0% |
| Goodwill | $39.0M-26.1% | $45.8M-13.3% | $45.8M-13.3% | $45.8M-13.3% | $52.8M0.0% | $52.8M0.0% | $52.8M0.0% | $52.8M0.0% |
| Total Liabilities | $439.8M-2.9% | $467.5M+0.9% | $464.8M+0.2% | $466.3M+3.1% | $452.9M-5.6% | $463.5M-4.3% | $464.0M-5.4% | $452.2M-3.6% |
| Total Equity | $491.5M+40.6% | $355.9M+11.1% | $335.5M+12.0% | $337.9M+12.8% | $349.5M+20.8% | $320.4M+19.9% | $299.5M+15.7% | $299.5M+9.6% |
| Retained Earnings | -$117.0Mn/m | -$230.8Mn/m | -$235.7Mn/m | -$240.0Mn/m | -$240.6Mn/m | -$261.3Mn/m | -$272.4Mn/m | -$274.7Mn/m |
Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Long-Term Investments, Current Liabilities, Non-Current Liabilities, Long-Term Debt.
IMAX Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $86.1M+27.5% | $32.0M+37.7% | $4.0M-42.0% | $29.4M+155.8% | $67.5M+91.4% | $23.2M-33.7% | $7.0Mn/m | $11.5M+186.6% |
| Depreciation & Amortization | $26.8M+71.9% | $15.7M-1.4% | $15.2M+2.2% | $16.0M-3.4% | $15.6M+4.7% | $15.9M-15.6% | $14.9M-1.7% | $16.6M+22.6% |
| Stock-Based Compensation | $9.8M+55.6% | $7.3M-1.4% | $5.7M+9.6% | N/A | $6.3M+16.7% | $7.4M+7.2% | $5.2M+10.6% | N/A |
| Capital Expenditures | $1.9M-29.2% | $21K-99.1% | $2.1M+29.6% | $1.4M-69.3% | $2.7M+143.7% | $2.4M+48.9% | $1.6M+49.0% | $4.6M+16.8% |
| Free Cash Flow | $84.2M+29.9% | $32.0M+53.2% | $1.9M-64.2% | $28.0M+306.8% | $64.8M+89.6% | $20.9M-37.6% | $5.3Mn/m | $6.9M+11957.9% |
| Investing Cash Flow | -$8.7Mn/m | -$6.1Mn/m | -$6.9Mn/m | -$7.1Mn/m | -$12.7Mn/m | -$7.4Mn/m | -$14.6Mn/m | -$10.9Mn/m |
| Financing Cash Flow | -$29.8Mn/m | -$11.5Mn/m | -$2.8M-165.2% | -$13.7Mn/m | -$20.9Mn/m | -$3.8Mn/m | $4.2M-81.4% | -$5.1Mn/m |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | $0-100.0% | N/A |
Not reported in any period shown, so not listed: Dividends Paid.
IMAX Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 72.4%+9.3pp | 61.2%+2.7pp | 56.3%-5.1pp | 57.6%+5.4pp | 63.1%+7.3pp | 58.5%+9.1pp | 61.4%+2.1pp | 52.2%+1.4pp |
| Operating Margin | 42.9%+15.7pp | 20.2%+4.6pp | 12.2%-7.1pp | 19.3%+9.0pp | 27.2%+6.0pp | 15.7%+12.4pp | 19.3%+4.1pp | 10.3%+7.1pp |
| Net Margin | 65.2%+45.8pp | 15.0%+2.7pp | 5.2%+2.5pp | 0.5%-5.2pp | 19.4%+4.2pp | 12.3%+8.3pp | 2.7%-1.5pp | 5.7%+2.8pp |
| Return on Equity | 23.2%+17.2pp | 4.3%+0.8pp | 1.3%+0.5pp | 0.2%-1.6pp | 5.9%+1.1pp | 3.5%+2.2pp | 0.8%-0.5pp | 1.8%+0.8pp |
| Return on Assets | 11.1%+8.7pp | 1.7%+0.4pp | 0.5%+0.2pp | 0.1%-0.6pp | 2.3%+0.7pp | 1.3%+0.9pp | 0.3%-0.1pp | 0.6%+0.3pp |
| Liabilities-to-Equity | 0.89-0.4x | 1.31-0.1x | 1.39-0.2x | 1.38-0.1x | 1.30-0.4x | 1.45-0.4x | 1.55-0.3x | 1.51-0.2x |
| Asset Turnover | 0.170.0x | 0.110.0x | 0.090.0x | 0.140.0x | 0.120.0x | 0.110.0x | 0.100.0x | 0.110.0x |
| FCF Margin | 48.2%-12.5pp | 31.1%+8.3pp | 2.3%-3.8pp | 22.3%+14.9pp | 60.7%+23.4pp | 22.8%-14.8pp | 6.1%+21.4pp | 7.4%+7.3pp |
Not reported in any period shown, so not listed: Current Ratio, Debt-to-Equity.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Imax Corp IMAX | FY2025 | $410.2M | $34.9M | 8.5% | $2.6B | 57/100 |
| AMC Entertainment Holdings, Inc. AMC | FY2025 | $4.8B | -$632.4M | -13.0% | $2.8B | 19/100 |
| Madison Square Garden Entertainment Corp. MSGE | FY2026 | $1.1B | $66.2M | 6.2% | $3.8B | 49/100 |
| Atlanta Braves Holdings, Inc. BATRK | FY2025 | $732.5M | -$23.4M | -3.2% | $3.3B | 26/100 |
| Cinemark Holdings, Inc. CNK | FY2025 | $3.1B | $138.2M | 4.4% | $4.7B | 29/100 |
| Manchester United plc MANU | FY2026 | $898.5M | -$57.0M | -6.3% | $3.7B | 28/100 |
Where Imax Corp Ranks
Frequently Asked Questions
Imax Corp (IMAX) reported $410.2M in total revenue for fiscal year 2025. This represents a 16.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Imax Corp (IMAX) revenue grew by 16.5% year-over-year, from $352.2M to $410.2M in fiscal year 2025.
Yes, Imax Corp (IMAX) reported a net income of $134.1M over the trailing 12 months to September 30, 2026. In fiscal year 2025 it reported a net income of $34.9M, with a net profit margin of 8.5%.
Imax Corp (IMAX) had EBITDA of $146.7M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
Imax Corp (IMAX) had a gross margin of 60.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
Imax Corp (IMAX) had an operating margin of 20.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
Imax Corp (IMAX) had a net profit margin of 8.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
Imax Corp (IMAX) has a return on equity of 10.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
Imax Corp (IMAX) generated $118.9M in free cash flow during fiscal year 2025. This represents a 90.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Imax Corp (IMAX) generated $127.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
Imax Corp (IMAX) had $894.0M in total assets as of fiscal year 2025, including both current and long-term assets.
Imax Corp (IMAX) invested $8.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
Imax Corp (IMAX) invested $5.8M in research and development during fiscal year 2025.
Imax Corp (IMAX) had a liabilities-to-equity ratio of 1.38 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.
Imax Corp (IMAX) had a return on assets of 3.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
Imax Corp (IMAX) trades at 19.4x earnings, its market capitalization divided by $134.1M net income, trailing 12 months to September 30, 2026. The market capitalization is $2.6B as of Nov 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Imax Corp (IMAX) trades at 5.4x sales, its market capitalization divided by $484.0M revenue, trailing 12 months to September 30, 2026. The market capitalization is $2.6B as of Nov 17, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Imax Corp (IMAX) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Imax Corp (IMAX) has an earnings quality ratio of 3.64x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Imax Corp (IMAX) has an interest coverage ratio of 11.44x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
Imax Corp (IMAX) scores 57 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For Imax Corp it averages the 4 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.